Vertex Pharmaceuticals on Track for Record High Close — Data Talk
Vertex Pharmaceuticals Incorporated (VRTX) is currently at $468.98, up $13.64 or 3%
--Would be new all-time high (Based on available data back to July 24, 1991)
--On pace for largest percent increase since Dec. 13, 2023, when it rose 13.23%
--Currently up three consecutive days; up 6.31% over this period
--Best three day stretch since the three days ending Dec. 15, 2023, when it rose 14.8%
--Up 15.26% year-to-date
--Up 40.24% from 52 weeks ago (June 5, 2023), when it closed at $334.42
--Would be a new 52-week closing high
--Up 44.46% from its 52-week closing low of $324.65 on June 7, 2023
--Traded as high as $468.98; new all-time intraday high (Based on available data back to July 24, 1991)
--Up 3% at today's intraday high
--Eighth best performer in the S&P 500 today
--Fifth best performer in the Nasdaq 100 today
All data as of 11:19:10 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 03, 2024 11:36 ET (15:36 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks